<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10425206" created="28/08/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10425206</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="PPARgamma_activation" sem="Other"><term id="T2" lex="PPARgamma" sem="Protein_molecule">PPARgamma</term> activation</term> induces the expression of the <term id="T3" lex="adipocyte_fatty_acid_binding_protein_gene" sem="DNA_domain_or_region"><term id="T4" lex="adipocyte_fatty_acid_binding_protein" sem="Protein_molecule">adipocyte fatty acid binding protein</term> gene</term> in <term id="T5" lex="human_monocyte" sem="Cell_natural">human monocytes</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<clue>PPARgamma <clueType>activation</clueType> induces the expression of the adipocyte fatty acid binding protein gene in human monocytes.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="E1"/>
<clue>PPARgamma activation <clueType>induces</clueType> the expression of the adipocyte fatty acid binding protein gene in human monocytes.</clue>
</event>
<event id="E3">
<type class="Gene_expression"/>
<theme idref="T4"/>
<clue>PPARgamma activation induces the <clueType>expression</clueType> <linkTheme>of</linkTheme> the adipocyte fatty acid binding protein gene <clueLoc>in human monocytes</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T6" lex="peroxisome-proliferator_activated_receptor_gamma" sem="Protein_molecule">peroxisome-proliferator activated receptor gamma</term> (<term id="T7" lex="PPARgamma" sem="Protein_molecule">PPARgamma</term>), a member of the <term id="T8" lex="nuclear_receptor_superfamily" sem="Protein_family_or_group">nuclear receptor superfamily</term> of <term id="T9" lex="ligand_activated_transcription_factor" sem="Protein_family_or_group">ligand activated transcription factors</term>, plays a key role in the <term id="T10" lex="anti-diabetic_action" sem="Other">anti-diabetic actions</term> of the <term id="T11" lex="thiazolidinedione" sem="Organic_compound_other">thiazolidinediones</term> (<term id="T12" lex="TZD" sem="Organic_compound_other">TZDs</term>).</sentence>
<event KT="Fact" id="E4">
<type class="Regulation"/>
<theme idref="E5"/>
<cause idref="T7"/>
<clue>The peroxisome-proliferator activated receptor gamma (PPARgamma), a member of the nuclear receptor superfamily of ligand activated transcription factors, <clueType>plays</clueType> a key <clueType>role</clueType> <linkTheme>in</linkTheme> the anti-diabetic actions of the thiazolidinediones (TZDs).</clue>
</event>
<event KT="Other" id="E5">
<type class="Biological_process"/>
<cause idref="T12"/>
<clue>The peroxisome-proliferator activated receptor gamma (PPARgamma), a member of the nuclear receptor superfamily of ligand activated transcription factors, plays a key role in the <clueType>anti-diabetic actions</clueType> <linkCause>of</linkCause> the thiazolidinediones (TZDs).</clue>
<comment>NO THEME</comment></event>
<sentence id="S3"><term id="T13" lex="PPARgamma" sem="Protein_molecule">PPARgamma</term> induces the expression of many <term id="T14" lex="gene" sem="DNA_family_or_group">genes</term> involved in <term id="T15" lex="lipid_anabolism" sem="Other"><term id="A2" sem="Lipid">lipid</term> anabolism</term>, including the <term id="T16" lex="adipocyte_fatty_acid_binding_protein" sem="Protein_molecule">adipocyte fatty acid binding protein</term> (<term id="T17" lex="aP2" sem="Protein_molecule">aP2</term>), and is a key regulator of <term id="T18" lex="adipocyte_differentiation" sem="Other"><term id="T19" lex="adipocyte" sem="Cell_natural">adipocyte</term> differentiation</term>.</sentence>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T13"/>
<clue>PPARgamma <clueType>induces</clueType> the expression of many genes involved in lipid anabolism, including the adipocyte fatty acid binding protein (aP2), and is a key regulator of adipocyte differentiation.</clue>
</event>
<event KT="Other" id="E7">
<type class="Gene_expression"/>
<theme idref="T17"/>
<clue>PPARgamma induces the <clueType>expression</clueType> <linkTheme>of</linkTheme> many <corefTheme>genes involved in lipid anabolism</corefTheme>, including the adipocyte fatty acid binding protein (aP2), and is a key regulator of adipocyte differentiation.</clue>
</event>
<event KT="Other" id="E8">
<type class="Regulation"/>
<theme idref="E26"/>
<cause idref="T14"/>
<clue>PPARgamma induces the expression of many genes <clueType>involved</clueType> <linkTheme>in</linkTheme> lipid anabolism, including the adipocyte fatty acid binding protein (aP2), and is a key regulator of adipocyte differentiation.</clue>
</event>
<event KT="Other" id="E26">
<type class="Metabolism"/>
<theme idref="A2"/>
<clue>PPARgamma induces the expression of many genes involved in lipid <clueType>anabolism</clueType>, including the adipocyte fatty acid binding protein (aP2), and is a key regulator of adipocyte differentiation.</clue>
</event>
<event KT="Fact" id="E9">
<type class="Regulation"/>
<theme idref="E10"/>
<cause idref="T13"/>
<clue>PPARgamma induces the expression of many genes involved in lipid anabolism, including the adipocyte fatty acid binding protein (aP2), and is a key <clueType>regulator</clueType> <linkTheme>of</linkTheme> adipocyte differentiation.</clue>
</event>
<event KT="Other" id="E10">
<type class="Cell_differentiation"/>
<theme idref="T19"/>
<clue>PPARgamma induces the expression of many genes involved in lipid anabolism, including the adipocyte fatty acid binding protein (aP2), and is a key regulator of adipocyte <clueType>differentiation</clueType>.</clue>
</event>
<sentence id="S4"><term id="T20" lex="PPARgamma" sem="Protein_molecule">PPARgamma</term> is also expressed in <term id="T21" lex="hematopoietic_cell" sem="Cell_natural">hematopoietic cells</term> and is up-regulated in activated <term id="T22" lex="monocyte/macrophage" sem="Cell_natural">monocytes/<term id="T23" lex="macrophage" sem="Cell_natural">macrophages</term></term>.</sentence>
<event KT="Fact" id="E11">
<type class="Gene_expression"/>
<theme idref="T20"/>
<clue>PPARgamma is also <clueType>expressed</clueType> <clueLoc>in hematopoietic cells</clueLoc> and is up-regulated in activated monocytes/macrophages.</clue>
</event>
<event KT="Fact" id="E12">
<type class="Positive_regulation"/>
<theme idref="T20"/>
<clue>PPARgamma is also expressed in hematopoietic cells and is <clueType>up-regulated</clueType> <clueLoc>in activated monocytes/macrophages</clueLoc>.</clue>
</event>
<event KT="Other" id="E13">
<type class="Physiological_process"/>
<theme idref="T22"/>
<clue>PPARgamma is also expressed in hematopoietic cells and is up-regulated in <clueType>activated</clueType> monocytes/macrophages.</clue>
</event>
<sentence id="S5">Activation of <term id="T24" lex="PPARgamma" sem="Protein_molecule">PPARgamma</term> may play a role in the induction of differentiation of <term id="T25" lex="macrophage" sem="Cell_natural">macrophages</term> to <term id="T26" lex="foam_cell" sem="Cell_natural">foam cells</term> that are associated with <term id="T27" lex="atherosclerotic_lesion" sem="Tissue_natural">atherosclerotic lesions</term>.</sentence>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="T24"/>
<clue><clueType>Activation</clueType> <linkTheme>of</linkTheme> PPARgamma may play a role in the induction of differentiation of macrophages to foam cells that are associated with atherosclerotic lesions.</clue>
</event>
<event CL="L1" KT="Analysis" id="E15" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E16"/>
<cause idref="E14"/>
<clue>Activation of PPARgamma <clueKT><clueCL>may</clueCL></clueKT> <clueType>play</clueType> a <clueType>role</clueType> <linkTheme>in</linkTheme> the induction of differentiation of macrophages to foam cells that are associated with atherosclerotic lesions.</clue>
</event>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<clue>Activation of PPARgamma may play a role in the <clueType>induction</clueType> <linkTheme>of</linkTheme> differentiation of macrophages to foam cells that are associated with atherosclerotic lesions.</clue>
</event>
<event KT="Other" id="E17">
<type class="Cell_differentiation"/>
<theme idref="T25"/>
<theme idref="T26"/>
<clue>Activation of PPARgamma may play a role in the induction of <clueType>differentiation</clueType> <linkTheme>of</linkTheme> macrophages <linkTheme>to</linkTheme> foam cells that are associated with atherosclerotic lesions.</clue>
</event>
<event KT="Fact" id="E18">
<type class="Cell_adhesion"/>
<theme idref="T26"/>
<theme idref="T27"/>
<clue>Activation of PPARgamma may play a role in the induction of differentiation of macrophages to foam cells that are <clueType>associated</clueType> <linkTheme>with</linkTheme> atherosclerotic lesions.</clue>
</event>
<sentence id="S6">We report that both <cons id="T28" lex="(AND natural_PPARgamma_agonist synthetic_PPARgamma_agonist)" sem="(AND Organic_compound_other Organic_compound_other)"><frag id="F1">natural</frag> and <frag id="F2">synthetic</frag> <frag id="F3"><term id="A1" sem="Organic_compound_other">PPARgamma agonists</term></frag></cons> induce time- and dose-dependent increases in <term id="T29" lex="aP2_mRNA" sem="RNA_molecule"><term id="T30" lex="aP2" sem="Protein_molecule">aP2</term> mRNA</term> in both <term id="T31" lex="primary_human_monocyte" sem="Cell_natural">primary <term id="T32" lex="human_monocyte" sem="Cell_natural">human monocytes</term></term> and the <term id="T33" lex="monocytic_cell_line" sem="Cell_cultured">monocytic cell line</term>, <term id="T34" lex="THP-1" sem="Cell_cultured">THP-1</term>.</sentence>
<event KT="Analysis" id="E19">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="A1"/>
<clue>We <clueKT>report</clueKT> that both natural and synthetic PPARgamma agonists <clueType>induce</clueType> time- and dose-dependent increases in aP2 mRNA in both primary human monocytes and the monocytic cell line, THP-1.</clue>
</event>
<event KT="Analysis" id="E28">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="A1"/>
<clue>We <clueKT>report</clueKT> that both natural and synthetic PPARgamma agonists <clueType>induce</clueType> time- and dose-dependent increases in aP2 mRNA in both primary human monocytes and the monocytic cell line, THP-1.</clue>
</event>
<event KT="Other" id="E20">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<clue>We report that both natural and synthetic PPARgamma agonists induce time- and dose-dependent <clueType>increases</clueType> <linkTheme>in</linkTheme> aP2 mRNA <clueLoc>in both primary human monocytes</clueLoc> and the monocytic cell line, THP-1.</clue>
</event>
<event KT="Other" id="E27">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<clue>We report that both natural and synthetic PPARgamma agonists induce time- and dose-dependent <clueType>increases</clueType> <linkTheme>in</linkTheme> aP2 mRNA <clueLoc>in</clueLoc> both primary human monocytes and <clueLoc>the monocytic cell line, THP-1</clueLoc>.</clue>
</event>
<sentence id="S7">These data suggest that <term id="T35" lex="PPARgamma_activation" sem="Other"><term id="T36" lex="PPARgamma" sem="Protein_molecule">PPARgamma</term> activation</term> may play a role in <term id="T37" lex="monocyte_differentiation" sem="Other"><term id="T38" lex="monocyte" sem="Cell_natural">monocyte</term> differentiation</term> and function analogous to its well-characterized role in <term id="T39" lex="adipocyte" sem="Cell_natural">adipocytes</term>.</sentence>
<event KT="Other" id="E21" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T36"/>
<clue>These data suggest that PPARgamma <clueType>activation</clueType> may play a role in monocyte differentiation and function analogous to its well-characterized role in adipocytes.</clue>
</event>
<event CL="L1" KT="Analysis" id="E22" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E23"/>
<cause idref="E21"/>
<clue>These data <clueKT>suggest</clueKT> that PPARgamma activation <clueCL>may</clueCL> <clueType>play</clueType> a <clueType>role</clueType> <linkTheme>in</linkTheme> monocyte differentiation and function analogous to its well-characterized role in adipocytes.</clue>
</event>
<event KT="Other" id="E23">
<type class="Cell_differentiation"/>
<theme idref="T38"/>
<clue>These data suggest that PPARgamma activation may play a role in monocyte <clueType>differentiation</clueType> and function analogous to its well-characterized role in adipocytes.</clue>
</event>
<event CL="L1" KT="Analysis" id="E24">
<type class="Correlation"/>
<theme idref="E22"/>
<theme idref="E25"/>
<clue>These data <clueKT>suggest</clueKT> that PPARgamma activation <clueCL>may</clueCL> play a role in monocyte differentiation and <clueType>function analogous</clueType> <linkTheme>to</linkTheme> its well-characterized role in adipocytes.</clue>
</event>
<event KT="Other" id="E25">
<type class="Regulation"/>
<cause idref="T36"/>
<clue>These data suggest that PPARgamma activation may play a role in monocyte differentiation and function analogous to its well-characterized <clueType>role</clueType> <clueLoc>in adipocytes</clueLoc>.</clue>
<comment>NO THEME</comment></event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
